We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$535M
AUM Growth
+$69.3M
(+15%)
Cap. Flow
+$21.1M
Cap. Flow
% of AUM
3.95%
Top 10 Holdings %
Top 10 Hldgs %
49.89%
Holding
688
New
58
Increased
157
Reduced
267
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$60M |
| 2 |
PepsiCo
PEP
|
+$9.31M |
| 3 |
TechnipFMC
FTI
|
+$8.19M |
| 4 |
WisdomTree India Earnings Fund ETF
EPI
|
+$7.88M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$7.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deutsche Bank
DB
|
+$14.4M |
| 2 |
Stellantis
STLA
|
+$8.39M |
| 3 |
iShares MSCI Philippines ETF
EPHE
|
+$7.31M |
| 4 |
iShares MSCI Poland ETF
EPOL
|
+$6.57M |
| 5 |
Canadian Imperial Bank of Commerce
CM
|
+$6.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.57% |
| 2 | Technology | 5.11% |
| 3 | Consumer Discretionary | 4.59% |
| 4 | Materials | 4.47% |
| 5 | Energy | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Regions Financial
RF
$26.3B
| $180K | 0.03% |
11,849
-7,708
| -39% | -$111K |
|
202
Delta Air Lines
DAL
$55.9B
| $177K | 0.03% |
3,678
+2,423
| +193% | +$121K |
|
|
SGYP
203
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $175K | 0.03% |
60,205
+52,722
| +705% | +$180K |
|
204
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$166M
| $171K | 0.03% |
7,593
-387
| -5% | -$8.16K |
|
205
Citigroup
C
$222B
| $171K | 0.03% |
2,352
-2,699
| -53% | -$184K |
|
|
CXO
206
DELISTED
CONCHO RESOURCES INC.
CXO
| $170K | 0.03% |
1,291
+253
| +24% | +$30.4K |
|
|
MNDT
207
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $168K | 0.03% |
+10,000
| New | +$154K |
|
208
Invesco Pharmaceuticals ETF
PJP
$425M
| $166K | 0.03% |
2,533
+740
| +41% | +$46.7K |
|
209
NVIDIA
NVDA
$5.01T
| $164K | 0.03% |
+36,640
| New | +$152K |
|
210
Archer Daniels Midland
ADM
$41.4B
| $163K | 0.03% |
3,826
-683
| -15% | -$28.8K |
|
211
LivaNova
LIVN
$4.3B
| $162K | 0.03% |
3,249
+93
| +3% | +$5.89K |
|
212
CALL
Rogers Communications
RCI
$17.7B
| $158K | 0.03% |
500
| – | – |
|
213
LyondellBasell Industries
LYB
$19.5B
| $156K | 0.03% |
1,577
-3,899
| -71% | -$351K |
|
|
FL
214
DELISTED
Foot Locker
FL
| $156K | 0.03% |
4,423
+4,419
| +110,475% | +$186K |
|
|
SKX
215
DELISTED
Skechers
SKX
| $152K | 0.03% |
6,072
+2,062
| +51% | +$56.3K |
|
216
Invesco QQQ Trust
QQQ
$455B
| $152K | 0.03% |
1,043
-69
| -6% | -$9.89K |
|
|
ETFC
217
DELISTED
E*Trade Financial Corporation
ETFC
| $148K | 0.03% |
3,383
-37
| -1% | -$1.5K |
|
218
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.64B
| $145K | 0.03% |
2,849
-188
| -6% | -$9.52K |
|
219
Williams-Sonoma
WSM
$26.7B
| $145K | 0.03% |
5,824
-4,024
| -41% | -$93.5K |
|
|
TAHO
220
DELISTED
Tahoe Resources Inc
TAHO
| $144K | 0.03% |
27,297
-46,717
| -63% | -$254K |
|
221
Adobe
ADBE
$89.5B
| $143K | 0.03% |
958
+340
| +55% | +$50.7K |
|
222
Zions Bancorporation
ZION
$10.1B
| $140K | 0.03% |
2,968
-29
| -1% | -$1.29K |
|
223
Texas Capital Bancshares
TCBI
$4.31B
| $137K | 0.03% |
1,596
-17
| -1% | -$1.32K |
|
|
BNY
224
Bank of New York Mellon
BNY
$108B
| $133K | 0.02% |
2,517
-25
| -1% | -$1.31K |
|
225
HealthEquity
HQY
$7.91B
| $133K | 0.02% |
2,622
-29
| -1% | -$1.35K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q3 2017 Portfolio in Review
As of Q3 2017, Exane Derivatives held 688 positions worth $535M, up 15% from $466M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Exane Derivatives deployed $21.1M of net new capital in Q3 2017, opening 58 new positions and adding to 157 existing holdings. Its largest new stake was PepsiCo: 80,581 shares worth $8.98M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Deutsche Bank, an estimated $14.4M trimmed.
- Exane Derivatives's largest Q3 2017 buy was PepsiCo: 80,581 shares worth $8.98M.
- Exane Derivatives added most to UBS Group in Q3 2017, an estimated $60M increase.
- Exane Derivatives's biggest Q3 2017 reduction was Deutsche Bank, cutting an estimated $14.4M.
- Exane Derivatives fully exited Stellantis in Q3 2017, selling an estimated $8.39M.
- Exane Derivatives's ten largest holdings make up 50% of its $535M portfolio in Q3 2017.
- Exane Derivatives opened 58 new positions and closed 121 in Q3 2017.
- Exane Derivatives's portfolio value rose 15% quarter-over-quarter to $535M.
Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.